传奇生物(LEGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LEGN 传奇生物

已收盘 07-26 16:00:00 EDT

56.61

-2.53

-4.28%

盘后56.61

+0.000.00%

19:54 EDT

最高59.42	最低55.93	成交量97.91万
今开58.57	昨收59.14	日振幅5.91%
总市值103.19亿	流通市值45.16亿	总股本1.82亿
成交额5,589万	换手率1.23%	流通股本7,977万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LEGN","market":"US","secType":"STK","nameCN":"传奇生物","latestPrice":56.61,"timestamp":1722024000000,"preClose":59.14,"halted":0,"volume":979059,"hourTrading":{"tag":"盘后","latestPrice":56.61,"preClose":56.61,"latestTime":"19:54 EDT","volume":10741,"amount":608018.26,"timestamp":1722038086830},"delay":0,"floatShares":79766382,"shares":182283494,"eps":-2.584684,"marketStatus":"已收盘","marketStatusCode":5,"change":-2.53,"latestTime":"07-26 16:00:00 EDT","open":58.57,"high":59.42,"low":55.925,"amount":55892246.055479996,"amplitude":0.059097,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.584684,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1722240000000},"adr":0,"listingDate":1591329600000,"adjPreClose":59.14,"adrRate":2,"preHourTrading":{"tag":"盘前","latestPrice":58.5,"preClose":59.14,"latestTime":"09:27 EDT","volume":715,"amount":41829.05155,"timestamp":1722000458713},"postHourTrading":{"tag":"盘后","latestPrice":56.61,"preClose":56.61,"latestTime":"19:54 EDT","volume":10741,"amount":608018.26,"timestamp":1722038086830},"volumeRatio":0.985893,"impliedVol":0.7603,"impliedVolPercentile":0.9325},"requestUrl":"/m/hq/s/LEGN","defaultTab":"news","newsList":[{"id":"2454374555","title":"传奇生物盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454374555","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454374555?lang=zh_cn&edition=full","pubTime":"2024-07-27 03:02","pubTimestamp":1722020537,"startTime":"0","endTime":"0","summary":"北京时间2024年07月27日03时02分，传奇生物股票出现异动，股价急速下跌5.04%。截至发稿，该股报56.16美元/股，成交量56.8588万股，换手率0.31%，振幅5.36%。传奇生物股票所在的生物技术行业中，整体涨幅为0.00%。该信息摘要如下：金斯瑞生物科技公布，于2024年上半年，传奇生物预期取得经调整净亏损约9470万美元至1.097亿美元，预期净亏损为7540万美元至8740万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072703021896820dc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072703021896820dc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4588","LEGN","BK4585","BK4139"],"gpt_icon":0},{"id":"2454834741","title":"传奇生物(LEGN.US)预计上半年调整后净亏损至多1.1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454834741","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454834741?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:31","pubTimestamp":1722000697,"startTime":"0","endTime":"0","summary":"传奇生物(LEGN.US)预计，2024年上半年调整后净亏损约为9470万美元至1.097亿美元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/source/image/16865.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/source/image/16865.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1156430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4139","BK4585","BK4505","LEGN","BK4588"],"gpt_icon":0},{"id":"2454343826","title":"金斯瑞生物科技(01548)：传奇生物预期上半年净亏损为7540万美元至8740万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454343826","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454343826?lang=zh_cn&edition=full","pubTime":"2024-07-26 19:36","pubTimestamp":1721993782,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金斯瑞生物科技(01548)公布，于2024年上半年，传奇生物预期取得经调整净亏损约9470万美元至1.097亿美元，预期净亏损为7540万美元至8740万美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1156329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4585","BK1576","BK4505","HK0000320264.USD","LEGN","HK0000306685.HKD","BK4588","01548","HK0000320223.HKD","HK0000306701.USD","BK1583","BK1141"],"gpt_icon":0},{"id":"2453718240","title":"焦点-制药公司旨在更快地提供个性化癌症疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2453718240","media":"Reuters","labels":["Product Release"],"top":-1,"share":"https://www.laohu8.com/m/news/2453718240?lang=zh_cn&edition=full","pubTime":"2024-07-24 18:00","pubTimestamp":1721815220,"startTime":"0","endTime":"0","summary":"诺华公司在2017年推出首款CAR-T疗法时，治疗时间长达37天，而现在吉利德公司的治疗时间缩短至14天。该公司还希望将目前半自动化的某些生产环节完全自动化，并获得监管部门的批准，以缩短质量控制时间。有些 CAR-T 批准要求患者在接受其他三到四种治疗失败后再使用该疗法。美国已批准六种CAR-T疗法用于治疗血癌，包括淋巴瘤和某些形式的白血病。该公司表示正在努力进一步缩短治疗时间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235303.USD","TSVT","BK4559","JNJ","LU1571399168.USD","LU1267930813.SGD","LU0289739699.SGD","LU0792757196.USD","BK4534","LU1506573853.SGD","LEGN","LU0320765992.SGD","BK4550","BK4532","LU1585245621.USD","LU0912757837.SGD","BK4230","IE00B1BXHZ80.USD","LU1280957306.USD","GILD","LU1074936037.SGD","LU1261432733.SGD","BK4533","LU1066051225.USD","IE00BZ1G4Q59.USD","CAR","LU0795875169.SGD","LU1244550577.SGD","LU0320765646.SGD","LU0882574055.USD","LU1023059063.AUD","LU2468319806.SGD","BMY","LU1732799900.SGD","LU1732800096.USD","LU0122379950.USD","BK4007","LU1066053197.SGD","BK4566","LU1057294990.SGD","LU1066051498.USD","BK4583","IE0002270589.USD","LU1244550221.USD","IE000M9KFDE8.USD","LU0114720955.EUR","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU0058720904.USD","LU1066051811.HKD"],"gpt_icon":1},{"id":"2452410039","title":"港股异动 | 金斯瑞生物科技(01548)转跌逾4% 传奇生物不对收购传闻发表评论 公司或面临壳化风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2452410039","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452410039?lang=zh_cn&edition=full","pubTime":"2024-07-19 15:15","pubTimestamp":1721373303,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，金斯瑞生物科技早盘延续近期涨势，盘中一度涨超4%，午后股价转跌，尾盘跌幅扩大逾4%。传奇生物方面表示，企业方不会对此市场传闻发表任何评论。据悉，金斯瑞生物持有传奇生物47.96%的股份。如果最终将传奇生物授出，收获的现金远超金斯瑞当前市值，但公司未来存在“壳”化风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","YANG","BK4139","BK1141","01548","BK4585","BK4588","HK0000306685.HKD","HSCEI","HK0000320223.HKD","BK1576","BK4505","LEGN","HK0000306701.USD","BK1583","HK0000320264.USD"],"gpt_icon":1},{"id":"2452898480","title":"传奇生物盘中异动 大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452898480","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452898480?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:05","pubTimestamp":1721311500,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时05分，传奇生物股票出现波动，股价大幅上涨5.07%。截至发稿，该股报57.79美元/股，成交量9.9195万股，换手率0.05%，振幅5.42%。传奇生物股票所在的生物技术行业中，整体涨幅为0.03%。该信息摘要如下：巴克莱银行分析师Gena Wang维持$传奇生物 $买入评级，维持目标价94美元。根据TipRanks数据显示，该分析师近一年总胜率为48.1%，总平均回报率为10.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718220501aefa5805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718220501aefa5805&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEGN","BK4139","BK4588","BK4585","BK4505"],"gpt_icon":0},{"id":"2451234990","title":"传奇生物盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451234990","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451234990?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:40","pubTimestamp":1721137239,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时40分，传奇生物股票出现波动，股价大幅上涨5.20%。截至发稿，该股报56.80美元/股，成交量4.0887万股，换手率0.02%，振幅4.13%。传奇生物股票所在的生物技术行业中，整体涨幅为0.42%。当日，传奇生物股价大涨超12%，市值逼近100亿美元。当时，该交易创下中国药企对外专利授权首付款最大金额与合作最优条件的记录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162140449681d305&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162140449681d305&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4505","LEGN","BK4139"],"gpt_icon":0},{"id":"2451982355","title":"港股异动 | 金斯瑞生物科技(01548)回落逾4% 总市值超250亿港元 报道称传奇生物或收到并购要约","url":"https://stock-news.laohu8.com/highlight/detail?id=2451982355","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451982355?lang=zh_cn&edition=full","pubTime":"2024-07-16 10:07","pubTimestamp":1721095650,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，金斯瑞生物科技回落逾4%，截至发稿，跌3.67%，报12.08港元，成交额1.68亿港元，总市值超250亿港元。消息面上，据报道，传奇生物近日收到并购邀约，并聘请投资银行Centerview Partners帮助其董事会审查收购要约和其他选择。据悉，传奇生物为金斯瑞生物的子公司，金斯瑞生物持股比例为47.96%。据业内猜测，若本次潜在收购以30%-50%溢价计算，收购价格或将在130-150亿美元之间，出售事项完成后，金斯瑞生物科技到手现金约451.9-521.4亿人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151331.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000320223.HKD","HK0000320264.USD","BK1583","01548","BK1141","LEGN","07226","YANG","HSCEI","HSTECH","BK4588","BK4139","BK4585","HK0000306701.USD","HK0000306685.HKD","BK1576","BK4505"],"gpt_icon":0},{"id":"2451261566","title":"传奇生物(LEGN)盘中涨超5% 传交易收购价或在130亿-150亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451261566","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451261566?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:23","pubTimestamp":1721053397,"startTime":"0","endTime":"0","summary":"金吾财讯 | 传奇生物(LEGN)盘中涨超5%，截至发稿，报55.5美元。消息面上，Street Insider援引一位消息人士称，传奇生物近日收到并购提案，并聘请投资银行Centerview Partners帮助其董事会审查收购要约和其他选择。按照业内猜测，以30%-50%的溢价来算，此次交易收购价或将在130亿-150亿美元之间。这或将促成截至目前中国最大biotech并购案的诞生。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210625/YzgwNjg1MzE3MzA0ODEyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzgwNjg1MzE3MzA0ODEyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277789","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BK4588","LEGN","BK4585"],"gpt_icon":0},{"id":"2451628699","title":"传奇生物盘中异动 早盘股价大涨5.26%报57.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451628699","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451628699?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:33","pubTimestamp":1721050431,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时33分，传奇生物股票出现异动，股价急速拉升5.26%。截至发稿，该股报57.23美元/股，成交量17.2412万股，换手率0.09%，振幅3.48%。传奇生物股票所在的生物技术行业中，整体跌幅为0.18%。从地理上看，该公司的大部分收入来自美国。消息层面，截至21时33分，《传奇生物被曝收百亿美元并购要约，业内预计强生将参与竞争》资讯为影响传奇生物的重要信息。当日，传奇生物股价大涨超12%，市值逼近100亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213355aef9c02f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715213355aef9c02f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LEGN","BK4588","BK4139","BK4505"],"gpt_icon":0},{"id":"2451450916","title":"传奇生物收到并购邀约，被收购将成Biotech体面退出路径？","url":"https://stock-news.laohu8.com/highlight/detail?id=2451450916","media":"21财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451450916?lang=zh_cn&edition=full","pubTime":"2024-07-15 19:30","pubTimestamp":1721043043,"startTime":"0","endTime":"0","summary":"近日，有市场消息称，传奇生物收到并购邀约，并聘请投资银行Centerview Partners帮助其董事会审查收购要约和其他选择。若传奇生物该交易顺利进行，或将创下国内Biotech最大并购纪录。2023年12月，阿斯利康宣布将以总价12亿美元收购亘喜生物，是首个MNC收购国内Biotech的事件。种种迹象不难看出，中国明星Biotech被收购已经逐渐演变成常态。未来，或许有更多跨国药企收购Biotech事件发生，手握优质资产的中国Bi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071519305095c025e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071519305095c025e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LEGN","BK4585","BK4588","BK4505"],"gpt_icon":0},{"id":"2451612019","title":"核心CAR-T产品去年销售额达5亿美元，传奇生物收到并购要约","url":"https://stock-news.laohu8.com/highlight/detail?id=2451612019","media":"蓝鲸财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451612019?lang=zh_cn&edition=full","pubTime":"2024-07-15 18:17","pubTimestamp":1721038647,"startTime":"0","endTime":"0","summary":"传奇生物方面并未就此作出公开回应。截至2023年12月31日的年度业绩报告中，传奇生物公布，在2023年第四季度，CARVYKTI实现了全球销售额1.59亿美元，同比增长194%。目前，全球共获批上市 8 款 CAR-T 细胞治疗产品，其中有2款是BCMA CAR-T 疗法，一款是传奇生物的CARVYKTI，另一款是BMS旗下的Abecma。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/235038","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4505","BK4139","BK4022","LEGN","BK4588","CAR","BK4230","BK4585"],"gpt_icon":0},{"id":"1128136825","title":"传奇生物盘前续涨逾7%！消息称其近日收到百亿美元并购提案","url":"https://stock-news.laohu8.com/highlight/detail?id=1128136825","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1128136825?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:37","pubTimestamp":1721032649,"startTime":"0","endTime":"0","summary":"7月15日，$传奇生物(LEGN)$盘前续涨逾6%，上周五大幅收涨逾12%。Street Insider援引一位消息人士称，传奇生物近日收到并购提案，并聘请投资银行Centerview Partners帮助其董事会审查收购要约和其他选择。按照业内猜测，以30%-50%的溢价来算，此次交易收购价或将在130亿-150亿美元之间。这或将促成截至目前中国最大biotech并购案的诞生。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BK4585","BK4588","LEGN"],"gpt_icon":0},{"id":"2451615650","title":"传奇生物(LEGN)盘前涨超6% 传公司近日收到并购提案 收购价或为130亿-150亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451615650","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451615650?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:33","pubTimestamp":1721032388,"startTime":"0","endTime":"0","summary":"金吾财讯 | 传奇生物(LEGN)盘前涨超6%，截至发稿，涨6.68%，报58美元。消息面上，Street Insider援引一位消息人士称，传奇生物近日收到并购提案，并聘请投资银行Centerview Partners帮助其董事会审查收购要约和其他选择。按照业内猜测，以30%-50%的溢价来算，此次交易收购价或将在130亿-150亿美元之间。这或将促成截至目前中国最大biotech并购案的诞生。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/NWUyOTcwN2U1MzQ2YjViNjMyZDcwZGM2MmQ0YzE5MjMxNzMwNDc5NDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NWUyOTcwN2U1MzQ2YjViNjMyZDcwZGM2MmQ0YzE5MjMxNzMwNDc5NDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277751","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","BK4588","BK4139","BK4585","BK4505"],"gpt_icon":0},{"id":"2451692039","title":"传奇生物被曝收百亿美元并购要约，业内预计强生将参与竞争","url":"https://stock-news.laohu8.com/highlight/detail?id=2451692039","media":"界面","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451692039?lang=zh_cn&edition=full","pubTime":"2024-07-15 15:26","pubTimestamp":1721028404,"startTime":"0","endTime":"0","summary":"当日，传奇生物股价大涨超12%，市值逼近100亿美元。同日，界面新闻向金斯瑞生物和传奇生物询问该并购消息，双方均表示目前对此没有回应。传奇生物的首个高光时刻在其成立三年之后。另外，阿斯利康于2023年12月宣布收购国内CAR-T公司亘喜生物，加强其在血液瘤方面的布局。截至2024年第一季度末，传奇生物现金及其等价物、存款和短期投资为13亿美元。2023年，传奇生物亏损5.18亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071515273895bedde4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071515273895bedde4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1032955483.USD","BK4585","LU1074936037.SGD","LU1244550577.SGD","JNJ","LU1267930813.SGD","LU1585245621.USD","BK4505","LU0889566641.SGD","LU1221951129.SGD","LU1032466523.USD","LU1059921491.USD","LU1066051225.USD","LU0234572021.USD","BK4559","LU1244550221.USD","LU1929549753.HKD","BK4581","LU0912757837.SGD","SG9999001440.SGD","IE00BSNM7G36.USD","BK4007","LU0466842654.USD","LU1196500208.SGD","BK4139","BK4550","LEGN","LU1221951046.USD","LU1244550494.USD","LU0345770308.USD","LU2602419157.SGD","LU0640476718.USD","LU0882574055.USD","LU1066053197.SGD","LU1506573853.SGD","BK4504","LU0795875169.SGD","BK4588","LU2133065610.SGD","BK4592","LU2347655156.SGD","LU0345770993.USD","LU1935042991.SGD","BK4568","LU0795875086.SGD","LU1430594728.SGD","LU1162221912.USD","SG9999002224.SGD","IE00B19Z3581.USD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2451694902","title":"美国研究综述-Armada Hoffler Properties、Morphic Holding、Solid Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2451694902","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451694902?lang=zh_cn&edition=full","pubTime":"2024-07-15 15:19","pubTimestamp":1721027985,"startTime":"0","endTime":"0","summary":"    路透7月15日 - 华尔街证券分析师周一调整了对 Armada Hoffler Properties、Morphic Holding 和 Solid Biosciences 等几家美国上市公司的评级和目标价。要点             * Armada Hoffler Properties Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有             * Morphic Holding Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有              * Solid Biosciences Inc   ：摩根大通将其评级从中性上调至增持              * Valero Energy Corp   ：杰富瑞将目标价从184美元上调至191美元              * 富国银行  ：杰富瑞将目标价从 64 美元下调至 62 美元  以下是路透周一报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AESI","LU2023250843.SGD","OIS","KLXE","LU1668664300.SGD","CLB","LU2505996509.AUD","WRB","BK4107","SLDB","HP","TTD","SLB","HAL","BX","VLO","IE00BKVL7J92.USD","LU0011850046.USD","LU0098860793.USD","MPC","MORF","LU1917777945.USD","LU1244550221.USD","LU2505996681.GBP","ULTA","LU1670628061.USD","SND","LU2456880835.USD","TAP","LEGN","LU1720051017.SGD","BKR","LU2237443978.SGD","LU0149725797.USD","NOV","CHX","BLK","WHD","CVNA","LBRT","PTEN","AHH","EA","BK","BK4548","LU1366192091.USD","RNGR","NRIX","ACDC","WMB"],"gpt_icon":0},{"id":"1126208511","title":"港股异动 | 金斯瑞午后一度涨近30%，旗下传奇生物或被溢价收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1126208511","media":"老虎资讯综合","labels":["movement"],"top":-1,"share":"https://www.laohu8.com/m/news/1126208511?lang=zh_cn&edition=full","pubTime":"2024-07-15 13:15","pubTimestamp":1721020527,"startTime":"0","endTime":"0","summary":"7月15日， $金斯瑞生物科技$ 高开高走，午后一度涨近30%，截止发稿成交额已超7亿港元。传奇生物旗下的西达基奥仑赛是首个实现在海外上市的中国原创CAR-T细胞治疗药物，销售额持续增长，有望成为下一个\"十亿美元分子\"。自西达基奥仑赛海外上市以来，销售额持续在增长,2022年销售额为2.68亿美元，2023年已达到5亿美元。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","01548"],"gpt_icon":0},{"id":"2451566046","title":"传奇生物收到并购要约？母公司金斯瑞股价大涨26.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451566046","media":"第一财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451566046?lang=zh_cn&edition=full","pubTime":"2024-07-15 13:02","pubTimestamp":1721019736,"startTime":"0","endTime":"0","summary":"7月15日上午，在港股上市的金斯瑞生物科技（01548.HK）股价大涨26.20%，股价大涨背后，与一则传言有关。在过去的两天，市场传出消息称，金斯瑞生物科技旗下子公司传奇生物（LEGN.NS）近日收到并购要约，并聘请投资银行CenterviewPartners帮助其董事会审查收购要约和其他选择。市场更是猜测称，这或将促成截至目前中国最大Biotech并购案的诞生。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202407153131090238.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202407153131090238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LEGN","BK4588","BK4139","BK4585","BK4505"],"gpt_icon":0},{"id":"2451692606","title":"【港股通】金斯瑞生物科技(01548)涨22.2% 传附属公司传奇生物获并购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2451692606","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451692606?lang=zh_cn&edition=full","pubTime":"2024-07-15 11:07","pubTimestamp":1721012832,"startTime":"0","endTime":"0","summary":"金吾财讯 | 金斯瑞生物科技 早盘股价走高，高见13.28港元，涨逾32%，截至发稿，涨22.2%，报12.22港元，成交额5.54亿港元。消息面上，有报道称，近期，公司附属公司传奇生物收到了并购协议，并且已经委托投资银行Centerview Partners协助其董事会评估收购提案以及其他可能的选项。根据行业内部的预测，如果按照30%至50%的溢价来估算，这次传奇生物的收购价格可能在130亿至150亿美元的范围内。这可能将创造中国生物科技领域迄今为止最大的并购案例。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/OWNjYzkwNTM4YzEwMTc4NjgyODQzNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OWNjYzkwNTM4YzEwMTc4NjgyODQzNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940370","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","YANG","BK1141","01548","BK4139","07226","BK4585","BK4588","HK0000306685.HKD","HSCEI","HK0000320223.HKD","BK1576","BK4505","LEGN","HK0000306701.USD","BK1583","HK0000320264.USD"],"gpt_icon":0},{"id":"2451652267","title":"港股异动 | 金斯瑞生物科技(01548)高开15% 传奇生物确认收到并购邀约","url":"https://stock-news.laohu8.com/highlight/detail?id=2451652267","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451652267?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:22","pubTimestamp":1721006569,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，金斯瑞生物科技高开15%，上周五子公司传奇生物大涨12%。截至发稿，涨15%，报11.5港元，成交额394.26万港元。消息面上，据报道，传奇生物近日收到并购邀约，并聘请投资银行Centerview Partners帮助其董事会审查收购要约和其他选择。在去年底阿斯利康12亿美元收购亘喜生物的交易中，Centerview Partners是亘喜生物的独家财务顾问，促使最终交易溢价62%。这或将促成截至目前中国最大biotech并购案的诞生。据悉，传奇生物的大股东为金斯瑞生物科技，持股比例为47.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1583","BK4139","07226","HK0000320223.HKD","HK0000320264.USD","YANG","BK4505","BK1141","HK0000306701.USD","01548","HK0000306685.HKD","LEGN","BK4585","HSCEI","HSTECH","BK1576"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.legendbiotech.com","stockEarnings":[{"period":"1week","weight":0.0155},{"period":"1month","weight":0.3589},{"period":"3month","weight":0.3055},{"period":"6month","weight":0.0458},{"period":"1year","weight":-0.2125},{"period":"ytd","weight":-0.0171}],"compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0118},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.182},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"传奇生物科技有限公司是一家全球性的临床级生物制药公司，致力于肿瘤和其他适应症的新药的发现和开发。该公司的差异化技术、全球开发和制造战略及专业知识使其能够针对高未满足需求的适应症生成、测试和制造下一代细胞疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.065278},{"month":2,"riseRate":0.5,"avgChangeRate":0.025486},{"month":3,"riseRate":0.5,"avgChangeRate":-0.027354},{"month":4,"riseRate":0.75,"avgChangeRate":0.086701},{"month":5,"riseRate":0.5,"avgChangeRate":0.05248},{"month":6,"riseRate":1,"avgChangeRate":0.131481},{"month":7,"riseRate":0.6,"avgChangeRate":0.032892},{"month":8,"riseRate":0,"avgChangeRate":-0.060697},{"month":9,"riseRate":0.25,"avgChangeRate":0.018606},{"month":10,"riseRate":0.5,"avgChangeRate":0.020275},{"month":11,"riseRate":0.5,"avgChangeRate":0.021203},{"month":12,"riseRate":0,"avgChangeRate":-0.047373}],"exchange":"NASDAQ","name":"传奇生物","nameEN":"Legend Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"传奇生物(LEGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供传奇生物(LEGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"传奇生物,LEGN,传奇生物股票,传奇生物股票老虎,传奇生物股票老虎国际,传奇生物行情,传奇生物股票行情,传奇生物股价,传奇生物股市,传奇生物股票价格,传奇生物股票交易,传奇生物股票购买,传奇生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"传奇生物(LEGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供传奇生物(LEGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}